These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 21061190)
1. Comparison of (99m)Tc-labeled PR81 and its F(ab')₂ fragments as radioimmunoscintigraphy agents for breast cancer imaging. Salouti M; Babaei MH; Rajabi H; Foroutan H; Rasaee MJ; Rajabi AB; Mohammadnejad J; Shafiee M; Mazidi M; Daha FJ Ann Nucl Med; 2011 Feb; 25(2):87-92. PubMed ID: 21061190 [TBL] [Abstract][Full Text] [Related]
2. Breast tumor targeting with (99m)Tc-HYNIC-PR81 complex as a new biologic radiopharmaceutical. Salouti M; Rajabi H; Babaei MH; Rasaee MJ Nucl Med Biol; 2008 Oct; 35(7):763-8. PubMed ID: 18848661 [TBL] [Abstract][Full Text] [Related]
3. Radioimmunotherapy of MCF7 breast cancer cell line with 131I-PR81 monoclonal antibody against MUC1: comparison of direct and indirect radioiodination methods. Mohammadnejad J; Rasaee MJ; Babaei MH; Paknejad M; Hasan ZM; Salouti M; Gandomkar M; Sadri K Hum Antibodies; 2010; 19(1):15-25. PubMed ID: 20555127 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies. Brouwers A; Mulders P; Oosterwijk E; Buijs W; Corstens F; Boerman O; Oyen W Cancer Biother Radiopharm; 2004 Aug; 19(4):466-77. PubMed ID: 15453961 [TBL] [Abstract][Full Text] [Related]
5. Optimization of IGF-1R SPECT/CT imaging using 111In-labeled F(ab')2 and Fab fragments of the monoclonal antibody R1507. Heskamp S; van Laarhoven HW; Molkenboer-Kuenen JD; Bouwman WH; van der Graaf WT; Oyen WJ; Boerman OC Mol Pharm; 2012 Aug; 9(8):2314-21. PubMed ID: 22747077 [TBL] [Abstract][Full Text] [Related]
6. Biodistribution and planar gamma camera imaging of (123)I- and (131)I-labeled F(ab')(2) and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumor. Burvenich IJ; Schoonooghe S; Blanckaert P; Bacher K; Vervoort L; Coene E; Mertens N; De Vos F; Slegers G Nucl Med Biol; 2007 Apr; 34(3):257-65. PubMed ID: 17383575 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and preliminary evaluation of Suman SK; Kameswaran M; Mallia M; Mittal S; Dash A Appl Radiat Isot; 2019 Nov; 153():108808. PubMed ID: 31325798 [TBL] [Abstract][Full Text] [Related]
8. Development of [⁶⁴Cu]-DOTA-PR81 radioimmunoconjugate for MUC-1 positive PET imaging. Alirezapour B; Rasaee MJ; Jalilian AR; Rajabifar S; Mohammadnejad J; Paknejad M; Maadi E; Moradkhani S Nucl Med Biol; 2016 Jan; 43(1):73-80. PubMed ID: 26453525 [TBL] [Abstract][Full Text] [Related]
9. Biodistribution properties of (111)indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab')(2) constructs in a breast carcinoma xenograft model. Tahtis K; Lee FT; Smyth FE; Power BE; Renner C; Brechbiel MW; Old LJ; Hudson PJ; Scott AM Clin Cancer Res; 2001 Apr; 7(4):1061-72. PubMed ID: 11309358 [TBL] [Abstract][Full Text] [Related]
10. A new radiopharmaceutical compound (131I-PR81) for radioimmunotherapy of breast cancer: labeling of antibody and its quality control. Mohammadnejad J; Rasaee MJ; Babaei MH; Paknejad M; Zahir MH; Salouti M; Rajabi AB; Mazidi M Hum Antibodies; 2010; 19(4):79-88. PubMed ID: 21178279 [TBL] [Abstract][Full Text] [Related]
11. Comparative study of intact A7 MoAb and F(ab')2 fragments for radioimmunoimaging of human colon cancer in nude mice. Kojima S; Suzuki N; Shimura N; Kubodera A; Kubota K; Yamaguchi T; Takahashi T; Oyamada H Nucl Med Biol; 1993 Apr; 20(3):243-8. PubMed ID: 8485482 [TBL] [Abstract][Full Text] [Related]
12. Biodistribution of radiolabeled monoclonal antibody E48 IgG and F(ab')2 in patients with head and neck cancer. de Bree R; Roos JC; Quak JJ; den Hollander W; Wilhelm AJ; van Lingen A; Snow GB; Dongen GA Clin Cancer Res; 1995 Mar; 1(3):277-86. PubMed ID: 9815983 [TBL] [Abstract][Full Text] [Related]
13. Preclinical Evaluation of Shi D; Fu W; Tan H; Lin Q; Shi H; Cheng D Mol Pharm; 2024 Jan; 21(1):303-312. PubMed ID: 38109713 [TBL] [Abstract][Full Text] [Related]
14. MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using (64)Cu-NOTA-panitumumab F(ab')2 fragments. Boyle AJ; Cao PJ; Hedley DW; Sidhu SS; Winnik MA; Reilly RM Nucl Med Biol; 2015 Feb; 42(2):71-7. PubMed ID: 25456837 [TBL] [Abstract][Full Text] [Related]
15. Radioimmunoimaging of human breast carcinoma xenografts in nude mouse model with 111In-labeled new monoclonal antibody EBA-1 and F(ab')2 fragments. Yemul S; Leon JA; Pozniakoff T; Esser PD; Estabrook A Nucl Med Biol; 1993 Apr; 20(3):325-35. PubMed ID: 8485492 [TBL] [Abstract][Full Text] [Related]
16. Imaging of HER2/neu expression in BT-474 human breast cancer xenografts in athymic mice using [(99m)Tc]-HYNIC-trastuzumab (Herceptin) Fab fragments. Tang Y; Scollard D; Chen P; Wang J; Holloway C; Reilly RM Nucl Med Commun; 2005 May; 26(5):427-32. PubMed ID: 15838425 [TBL] [Abstract][Full Text] [Related]
18. Preparation and biological evaluation of (177)Lu conjugated PR81 for radioimmunotherapy of breast cancer. Salouti M; Babaei MH; Rajabi H; Rasaee Mj Nucl Med Biol; 2011 Aug; 38(6):849-55. PubMed ID: 21843781 [TBL] [Abstract][Full Text] [Related]
19. Effect of unlabelled monoclonal antibodies on the biodistribution of 111In-labelled anti-prostate-specific acid phosphatase monoclonal antibodies in the mouse model. Peräalä-Heape M; Vihko P; Vihko R Anticancer Res; 1991; 11(3):1327-31. PubMed ID: 1888168 [TBL] [Abstract][Full Text] [Related]
20. Targeting human prostate cancer with 111In-labeled D2B IgG, F(ab')2 and Fab fragments in nude mice with PSMA-expressing xenografts. Lütje S; van Rij CM; Franssen GM; Fracasso G; Helfrich W; Eek A; Oyen WJ; Colombatti M; Boerman OC Contrast Media Mol Imaging; 2015; 10(1):28-36. PubMed ID: 24764162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]